Global News

Agennix announces corporate restructuring

Friday, August 24, 2012 02:48 PM

Agennix has announced a restructuring that involves staff reductions of approximately 55% of the company's workforce. The restructuring is being implemented to conserve cash as management determines the company’s next strategic steps.

More... »

BMS discontinues development of BMS-986094 for hepatitis C

Friday, August 24, 2012 02:45 PM

Bristol-Myers Squibb has discontinued development of BMS-986094 (formerly known as INX-189), a nucleotide polymerase (NS5B) inhibitor that was in phase II development for the treatment of hepatitis C. This decision was made in the interest of patient safety, based on a rapid, thorough and ongoing assessment of patients in a phase II study the company voluntarily suspended Aug. 1, 2012. The FDA subsequently placed the compound on clinical hold.

More... »

Northwest Bio gets OK for phase III brain cancer trial in the U.K.

Friday, August 24, 2012 09:00 AM

Northwest Biotherapeutics, a Bethesda, Md.-based biotech, has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) of the U.K. to proceed with the company's 300-patient phase III clinical trial of DCVax-L immune therapy for Glioblastoma multiforme brain cancer (GBM).

More... »

Leica Biosystems to acquire Aperio

Thursday, August 23, 2012 11:44 AM

An affiliate of Leica Biosystems, an anatomical pathology solutions company, has agreed to acquire Aperio, a provider of ePathology solutions. 

More... »

Transgenomic awarded NIH STTR grant for pancreatic cancer research

Thursday, August 23, 2012 11:15 AM

Transgenomic,an Omaha, Neb.-based global biotechnology company focused on personalized medicine, has been awarded a $100,000 Small Business Technology Transfer Program (STTR) phase I grant by the National Institutes of Health’s National Center For Advancing Translational Sciences.

More... »

West Pharma breaks ground on new manufacturing facility in India

Thursday, August 23, 2012 10:46 AM

West Pharmaceutical India Packaging, an indirect subsidiary of West Pharmaceutical Services, began construction of its new compression molding facility located in Sri City, India.

More... »

MiReven, Silence to evaluate delivery of novel microRNA-based therapeutics

Wednesday, August 22, 2012 02:05 PM

Silence Therapeutics, an RNA interference (RNAi) therapeutics company, has signed an agreement with MiReven, an Australian-based microRNA company, to assess the delivery potential of Silence's proprietary delivery systems with MiReven's novel microRNA-based therapeutics.

More... »

New England Biolabs achieves ISO 14001 recertification

Wednesday, August 22, 2012 01:45 PM

New England Biolabs, a producer and supplier reagents for the life science industry has received ISO 14001 recertification in recognition of the company's dedication to and outstanding record of achievement in its Environmental Management Systems (EMS).

More... »

Study confirms economic viability of orphan drugs positioned for unmet medical needs

Wednesday, August 22, 2012 12:35 PM

Orphan drugs, developed to treat rare diseases, have the potential to generate as much lifetime revenue as drugs used for more common health conditions, according to a study by Thomson Reuters’ intellectual property and science business.

More... »

PRECOS awarded HTA license, expands PDX drug discovery models

Wednesday, August 22, 2012 11:22 AM

Preclinical Oncology Services (PRECOS), a pre-clinical research and development service provider focused on oncology, has been awarded a license to store and research human tissue samples by the Human Tissue Authority (HTA).

More... »